Prediction of Acute Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy Using Dose-Volume Parameters From Functional Mapping on Gallium 68 Perfusion Positron Emission Tomography/Computed Tomography

The aim of this work was to compare anatomic and functional dose-volume parameters as predictors of acute radiation-induced lung toxicity (RILT) in patients with lung tumors treated with stereotactic body radiation therapy. Fifty-nine patients treated with stereotactic body radiation therapy were pr...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of radiation oncology, biology, physics Vol. 118; no. 4; pp. 952 - 962
Main Authors Lucia, François, Bourhis, David, Pinot, Fanny, Hamya, Mohamed, Goasduff, Gaëlle, Blanc-Béguin, Frédérique, Hennebicq, Simon, Mauguen, Maëlle, Kerleguer, Kevin, Schick, Ulrike, Consigny, Maëlys, Pradier, Olivier, Le Gal, Grégoire, Salaun, Pierre-Yves, Bourbonne, Vincent, Le Roux, Pierre-Yves
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 15.03.2024
Online AccessGet full text

Cover

Loading…
Abstract The aim of this work was to compare anatomic and functional dose-volume parameters as predictors of acute radiation-induced lung toxicity (RILT) in patients with lung tumors treated with stereotactic body radiation therapy. Fifty-nine patients treated with stereotactic body radiation therapy were prospectively included. All patients underwent gallium 68 lung perfusion positron emission tomography (PET)/computed tomography (CT) imaging before treatment. Mean lung dose (MLD) and volumes receiving x Gy (VxGy, 5-30 Gy) were calculated in 5 lung volumes: the conventional anatomic volume (AV) delineated on CT images, 3 lung functional volumes (FVs) defined on lung perfusion PET imaging (FV50%, FV70%, and FV90%; ie, the minimal volume containing 50%, 70%, and 90% of the total activity within the AV), and a low FV (LFV; LFV = AV − FV90%). The primary endpoint of this analysis was grade ≥2 acute RILT at 3 months as assessed with National Cancer Institute Common Terminology Criteria for Adverse Events version 5. Dose-volume parameters in patients with and without acute RILT were compared. Receiver operating characteristic curves assessing the ability of dose-volume parameters to discriminate between patients with and without acute RILT were generated, and area under the curve (AUC) values were calculated. Of the 59 patients, 10 (17%) had grade ≥2 acute RILT. The MLD and the VxGy in the AV and LFV were not statistically different between patients with and without acute RILT (P > .05). All functional parameters were significantly higher in acute RILT patients (P < .05). AUC values (95% CI) for MLD AV, LFV, FV50%, FV70%, and FV90% were 0.66 (0.46-0.85), 0.60 (0.39-0.80), 0.77 (0.63-0.91), 0.77 (0.64-0.91), and 0.75 (0.58-0.91), respectively. AUC values for V20Gy AV, LFV, FV50%, FV70%, and FV90% were 0.65 (0.44-0.87), 0.64 (0.46-0.83), 0.82 (0.69-0.95), 0.81 (0.67-0.96), and 0.75 (0.57-0.94), respectively. The predictive value of PET perfusion-based functional parameters outperforms the standard CT-based dose-volume parameters for the risk of grade ≥2 acute RILT. Functional parameters could be useful for guiding radiation therapy planning and reducing the risk of acute RILT.
AbstractList PURPOSEThe aim of this work was to compare anatomic and functional dose-volume parameters as predictors of acute radiation-induced lung toxicity (RILT) in patients with lung tumors treated with stereotactic body radiation therapy.METHODS AND MATERIALSFifty-nine patients treated with stereotactic body radiation therapy were prospectively included. All patients underwent gallium 68 lung perfusion positron emission tomography (PET)/computed tomography (CT) imaging before treatment. Mean lung dose (MLD) and volumes receiving x Gy (VxGy, 5-30 Gy) were calculated in 5 lung volumes: the conventional anatomic volume (AV) delineated on CT images, 3 lung functional volumes (FVs) defined on lung perfusion PET imaging (FV50%, FV70%, and FV90%; ie, the minimal volume containing 50%, 70%, and 90% of the total activity within the AV), and a low FV (LFV; LFV = AV - FV90%). The primary endpoint of this analysis was grade ≥2 acute RILT at 3 months as assessed with National Cancer Institute Common Terminology Criteria for Adverse Events version 5. Dose-volume parameters in patients with and without acute RILT were compared. Receiver operating characteristic curves assessing the ability of dose-volume parameters to discriminate between patients with and without acute RILT were generated, and area under the curve (AUC) values were calculated.RESULTSOf the 59 patients, 10 (17%) had grade ≥2 acute RILT. The MLD and the VxGy in the AV and LFV were not statistically different between patients with and without acute RILT (P > .05). All functional parameters were significantly higher in acute RILT patients (P < .05). AUC values (95% CI) for MLD AV, LFV, FV50%, FV70%, and FV90% were 0.66 (0.46-0.85), 0.60 (0.39-0.80), 0.77 (0.63-0.91), 0.77 (0.64-0.91), and 0.75 (0.58-0.91), respectively. AUC values for V20Gy AV, LFV, FV50%, FV70%, and FV90% were 0.65 (0.44-0.87), 0.64 (0.46-0.83), 0.82 (0.69-0.95), 0.81 (0.67-0.96), and 0.75 (0.57-0.94), respectively.CONCLUSIONSThe predictive value of PET perfusion-based functional parameters outperforms the standard CT-based dose-volume parameters for the risk of grade ≥2 acute RILT. Functional parameters could be useful for guiding radiation therapy planning and reducing the risk of acute RILT.
The aim of this work was to compare anatomic and functional dose-volume parameters as predictors of acute radiation-induced lung toxicity (RILT) in patients with lung tumors treated with stereotactic body radiation therapy. Fifty-nine patients treated with stereotactic body radiation therapy were prospectively included. All patients underwent gallium 68 lung perfusion positron emission tomography (PET)/computed tomography (CT) imaging before treatment. Mean lung dose (MLD) and volumes receiving x Gy (VxGy, 5-30 Gy) were calculated in 5 lung volumes: the conventional anatomic volume (AV) delineated on CT images, 3 lung functional volumes (FVs) defined on lung perfusion PET imaging (FV50%, FV70%, and FV90%; ie, the minimal volume containing 50%, 70%, and 90% of the total activity within the AV), and a low FV (LFV; LFV = AV - FV90%). The primary endpoint of this analysis was grade ≥2 acute RILT at 3 months as assessed with National Cancer Institute Common Terminology Criteria for Adverse Events version 5. Dose-volume parameters in patients with and without acute RILT were compared. Receiver operating characteristic curves assessing the ability of dose-volume parameters to discriminate between patients with and without acute RILT were generated, and area under the curve (AUC) values were calculated. Of the 59 patients, 10 (17%) had grade ≥2 acute RILT. The MLD and the VxGy in the AV and LFV were not statistically different between patients with and without acute RILT (P > .05). All functional parameters were significantly higher in acute RILT patients (P < .05). AUC values (95% CI) for MLD AV, LFV, FV50%, FV70%, and FV90% were 0.66 (0.46-0.85), 0.60 (0.39-0.80), 0.77 (0.63-0.91), 0.77 (0.64-0.91), and 0.75 (0.58-0.91), respectively. AUC values for V20Gy AV, LFV, FV50%, FV70%, and FV90% were 0.65 (0.44-0.87), 0.64 (0.46-0.83), 0.82 (0.69-0.95), 0.81 (0.67-0.96), and 0.75 (0.57-0.94), respectively. The predictive value of PET perfusion-based functional parameters outperforms the standard CT-based dose-volume parameters for the risk of grade ≥2 acute RILT. Functional parameters could be useful for guiding radiation therapy planning and reducing the risk of acute RILT.
The aim of this work was to compare anatomic and functional dose-volume parameters as predictors of acute radiation-induced lung toxicity (RILT) in patients with lung tumors treated with stereotactic body radiation therapy. Fifty-nine patients treated with stereotactic body radiation therapy were prospectively included. All patients underwent gallium 68 lung perfusion positron emission tomography (PET)/computed tomography (CT) imaging before treatment. Mean lung dose (MLD) and volumes receiving x Gy (VxGy, 5-30 Gy) were calculated in 5 lung volumes: the conventional anatomic volume (AV) delineated on CT images, 3 lung functional volumes (FVs) defined on lung perfusion PET imaging (FV50%, FV70%, and FV90%; ie, the minimal volume containing 50%, 70%, and 90% of the total activity within the AV), and a low FV (LFV; LFV = AV − FV90%). The primary endpoint of this analysis was grade ≥2 acute RILT at 3 months as assessed with National Cancer Institute Common Terminology Criteria for Adverse Events version 5. Dose-volume parameters in patients with and without acute RILT were compared. Receiver operating characteristic curves assessing the ability of dose-volume parameters to discriminate between patients with and without acute RILT were generated, and area under the curve (AUC) values were calculated. Of the 59 patients, 10 (17%) had grade ≥2 acute RILT. The MLD and the VxGy in the AV and LFV were not statistically different between patients with and without acute RILT (P > .05). All functional parameters were significantly higher in acute RILT patients (P < .05). AUC values (95% CI) for MLD AV, LFV, FV50%, FV70%, and FV90% were 0.66 (0.46-0.85), 0.60 (0.39-0.80), 0.77 (0.63-0.91), 0.77 (0.64-0.91), and 0.75 (0.58-0.91), respectively. AUC values for V20Gy AV, LFV, FV50%, FV70%, and FV90% were 0.65 (0.44-0.87), 0.64 (0.46-0.83), 0.82 (0.69-0.95), 0.81 (0.67-0.96), and 0.75 (0.57-0.94), respectively. The predictive value of PET perfusion-based functional parameters outperforms the standard CT-based dose-volume parameters for the risk of grade ≥2 acute RILT. Functional parameters could be useful for guiding radiation therapy planning and reducing the risk of acute RILT.
Author Blanc-Béguin, Frédérique
Lucia, François
Kerleguer, Kevin
Le Roux, Pierre-Yves
Goasduff, Gaëlle
Pradier, Olivier
Le Gal, Grégoire
Salaun, Pierre-Yves
Hamya, Mohamed
Schick, Ulrike
Mauguen, Maëlle
Bourhis, David
Bourbonne, Vincent
Pinot, Fanny
Consigny, Maëlys
Hennebicq, Simon
Author_xml – sequence: 1
  givenname: François
  surname: Lucia
  fullname: Lucia, François
  email: francois.lucia@chu-brest.fr
  organization: Radiation Oncology Department, University Hospital, Brest, France
– sequence: 2
  givenname: David
  surname: Bourhis
  fullname: Bourhis, David
  organization: Service de Médecine Nucléaire, CHRU de Brest, Brest, France
– sequence: 3
  givenname: Fanny
  surname: Pinot
  fullname: Pinot, Fanny
  organization: Service de Médecine Nucléaire, CHRU de Brest, Brest, France
– sequence: 4
  givenname: Mohamed
  surname: Hamya
  fullname: Hamya, Mohamed
  organization: LaTIM, INSERM, UMR 1101, University of Brest, Brest, France
– sequence: 5
  givenname: Gaëlle
  surname: Goasduff
  fullname: Goasduff, Gaëlle
  organization: LaTIM, INSERM, UMR 1101, University of Brest, Brest, France
– sequence: 6
  givenname: Frédérique
  surname: Blanc-Béguin
  fullname: Blanc-Béguin, Frédérique
  organization: Service de Médecine Nucléaire, CHRU de Brest, Brest, France
– sequence: 7
  givenname: Simon
  surname: Hennebicq
  fullname: Hennebicq, Simon
  organization: Service de Médecine Nucléaire, CHRU de Brest, Brest, France
– sequence: 8
  givenname: Maëlle
  surname: Mauguen
  fullname: Mauguen, Maëlle
  organization: Radiation Oncology Department, University Hospital, Brest, France
– sequence: 9
  givenname: Kevin
  surname: Kerleguer
  fullname: Kerleguer, Kevin
  organization: Service de Médecine Nucléaire, CHRU de Brest, Brest, France
– sequence: 10
  givenname: Ulrike
  surname: Schick
  fullname: Schick, Ulrike
  organization: Radiation Oncology Department, University Hospital, Brest, France
– sequence: 11
  givenname: Maëlys
  surname: Consigny
  fullname: Consigny, Maëlys
  organization: Direction de la Recherche Clinique et de l'Innovation (DRCI), CHU Brest, Brest, France
– sequence: 12
  givenname: Olivier
  surname: Pradier
  fullname: Pradier, Olivier
  organization: Radiation Oncology Department, University Hospital, Brest, France
– sequence: 13
  givenname: Grégoire
  surname: Le Gal
  fullname: Le Gal, Grégoire
  organization: Department of Medicine, Ottawa Hospital Research Institute at the University of Ottawa, Ottawa, Ontario, Canada
– sequence: 14
  givenname: Pierre-Yves
  surname: Salaun
  fullname: Salaun, Pierre-Yves
  organization: Service de Médecine Nucléaire, CHRU de Brest, Brest, France
– sequence: 15
  givenname: Vincent
  surname: Bourbonne
  fullname: Bourbonne, Vincent
  organization: Radiation Oncology Department, University Hospital, Brest, France
– sequence: 16
  givenname: Pierre-Yves
  surname: Le Roux
  fullname: Le Roux, Pierre-Yves
  email: pierre-yves.leroux@chu-brest.fr
  organization: Service de Médecine Nucléaire, CHRU de Brest, Brest, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37875246$$D View this record in MEDLINE/PubMed
BookMark eNp9kV9v0zAUxS00xLrBN0DIj7yks-PESV-QSlnHpCIq6BBvlmtfb66SONgxIp91X2bOOv488WJbR-d3z7XOGTrpXAcIvaZkTgnlF4e5PXi37-c5yVmS5oQUz9CM1tUiY2X5_QTNCOMkY8l8is5COBBCKK2KF-iUVXVV5gWfofutB23VYF2HncFLFQfAX6S2cpKy605HBRpvYneLd-6XVXYY8dIM4PHXdIAbZIIVfu_0-JfDuzvwsh_xTbAJ_OACZN9cE1vAW-llCwkNeO1di9exe0yXDf4k-36yJ_5KNo2NLeY13oI3MUxDty7YwafHZWvDo7JzrbtNQXfjxcq1fdpd_6O9RM-NbAK8errP0c36crf6mG0-X12vlptMsbIaMm4YpUbnpVZ1Xi8WipOqIEZSYHShpdSUS8P2isiiIFIBJ6pQvNZasxyM3LNz9PY4t_fuR4QwiLSfgqaRHbgYRF7XtKKEl1WyFker8i4ED0b03rbSj4ISMdUqDuJYq5hqndRUa8LePCXEfQv6D_S7x2R4dzRA-udPC14EZaFL1VkPahDa2f8nPADd773f
Cites_doi 10.1002/cncr.26611
10.3390/cancers15072166
10.1118/1.4937599
10.1177/1533034614565534
10.1097/COC.0b013e3181979238
10.1259/bjr/71635286
10.1053/j.semnuclmed.2016.04.007
10.1007/s11523-016-0459-0
10.1016/j.ijrobp.2011.08.036
10.1001/jama.2010.261
10.3389/fonc.2021.674731
10.1016/j.ijrobp.2018.11.028
10.3390/cancers15061726
10.1016/S0140-6736(18)32487-5
10.1016/j.ijrobp.2016.05.012
10.1007/s00259-019-04338-z
10.1016/j.lungcan.2015.06.019
10.1016/j.ijrobp.2018.05.051
10.1016/j.ijrobp.2012.01.018
10.1016/j.canrad.2021.11.001
10.2967/jnumed.115.162586
10.3390/ph15050518
10.2967/jnumed.111.093344
10.1118/1.4888251
10.1016/S1470-2045(18)30896-9
10.1016/j.radonc.2023.109553
10.1016/j.radonc.2018.07.014
10.1053/j.semnuclmed.2018.10.013
ContentType Journal Article
Copyright 2023 Elsevier Inc.
Copyright © 2023 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2023 Elsevier Inc.
– notice: Copyright © 2023 Elsevier Inc. All rights reserved.
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.ijrobp.2023.10.004
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-355X
EndPage 962
ExternalDocumentID 10_1016_j_ijrobp_2023_10_004
37875246
S0360301623080082
Genre Journal Article
GroupedDBID ---
--K
.1-
.FO
0R~
1B1
1P~
1RT
1~5
4.4
457
4G.
53G
5RE
7-5
AAEDT
AAEDW
AAIAV
AALRI
AAWTL
AAXUO
ABJNI
ABLJU
ABNEU
ABOCM
ABUDA
ACGFS
ACIUM
ADBBV
AENEX
AEVXI
AFCTW
AFRHN
AFTJW
AGZHU
AHHHB
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
ALXNB
AMRAJ
BELOY
DU5
EBS
EFJIC
F5P
FDB
GBLVA
HED
HMO
IHE
J1W
KOM
MO0
O9-
OC~
OO-
RIG
RNS
ROL
RPZ
SDG
SEL
SES
SEW
SSZ
UV1
XH2
Z5R
ZA5
~S-
AFJKZ
AKRWK
LX3
M41
NPM
.55
.GJ
29J
5VS
AAQFI
AAQQT
AAQXK
AAYXX
ABEFU
ADMUD
ADPAM
ADVLN
AFFNX
AGRDE
ASPBG
AVWKF
AZFZN
CITATION
EJD
FEDTE
FGOYB
FIRID
G-2
HMK
HVGLF
HX~
HZ~
NQ-
R2-
SAE
UDS
X7M
XPP
ZGI
7X8
ID FETCH-LOGICAL-c357t-6f311fd25dc82899c60740fa1e319daad16af3bc0a440ace60c4c68ddd32efab3
ISSN 0360-3016
IngestDate Fri Oct 25 08:43:03 EDT 2024
Thu Sep 26 18:25:51 EDT 2024
Sat Nov 02 12:20:43 EDT 2024
Sat Mar 02 16:00:57 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License Copyright © 2023 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c357t-6f311fd25dc82899c60740fa1e319daad16af3bc0a440ace60c4c68ddd32efab3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1016/j.ijrobp.2023.10.004
PMID 37875246
PQID 2881710657
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_2881710657
crossref_primary_10_1016_j_ijrobp_2023_10_004
pubmed_primary_37875246
elsevier_sciencedirect_doi_10_1016_j_ijrobp_2023_10_004
PublicationCentury 2000
PublicationDate 2024-03-15
PublicationDateYYYYMMDD 2024-03-15
PublicationDate_xml – month: 03
  year: 2024
  text: 2024-03-15
  day: 15
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle International journal of radiation oncology, biology, physics
PublicationTitleAlternate Int J Radiat Oncol Biol Phys
PublicationYear 2024
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Le Roux, Iravani, Callahan (bib0013) 2019; 46
Berg, Ramberg, Haugstvedt (bib0029) 2021; 11
Hofman, Beauregard, Barber (bib0014) 2011; 52
Palma, Olson, Harrow (bib0002) 2019; 393
National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE). 2017. Available at
Siva, Devereux, Ball (bib0027) 2016; 15
Ferrero, Badellino, Filippi (bib0030) 2015; 89
Ball, Mai, Vinod (bib0001) 2019; 20
Kishi, Matsuo, Yoneyama (bib0010) 2022; 7
Su, Liu, Chen (bib0024) 2017; 12
Blanc-Béguin, Hennebicq, Robin (bib0019) 2022; 15
Lee, Zeng, Vesselle (bib0028) 2018; 102
Kipritidis, Hofman, Siva (bib0031) 2016; 43
Timmerman, Paulus, Galvin (bib0005) 2010; 303
Le Roux, Siva, Steinfort (bib0015) 2015; 56
Kadoya, Nakajima, Saito (bib0021) 2016; 96
Pinot, Bourhis, Bourbonne (bib0020) 2023; 15
Nelson, Duchateau, Piper (bib0022) 2014; 41
Lucia, Rehn, Blanc-Béguin (bib0011) 2021; 8
Salama, Hasselle, Chmura (bib0004) 2012; 118
Flakus, Kent, Wallat (bib0032) 2023; 182
Le Roux, Hicks, Siva (bib0017) 2019; 49
Milano, Katz, Okunieff (bib0026) 2010; 33
Bailey, Eslick, Schembri (bib0016) 2016; 46
Noël, Antoni (bib0018) 2022; 26
Milano, Katz, Zhang (bib0003) 2012; 83
Bucknell, Hardcastle, Bressel (bib0012) 2018; 129
Matsuo, Shibuya, Nakamura (bib0009) 2012; 83
Accessed November 10, 2023.
Spring Kong, Moiseenko, Zhao (bib0008) 2021; 110
Lucia, Hamya, Pinot (bib0006) 2023; 15
Takeda, Ohashi, Kunieda (bib0007) 2012; 85
Johnson, Cortazar, Chute (bib0025) 1997; 24
Kishi (10.1016/j.ijrobp.2023.10.004_bib0010) 2022; 7
Lucia (10.1016/j.ijrobp.2023.10.004_bib0011) 2021; 8
Milano (10.1016/j.ijrobp.2023.10.004_bib0026) 2010; 33
Lee (10.1016/j.ijrobp.2023.10.004_bib0028) 2018; 102
Kipritidis (10.1016/j.ijrobp.2023.10.004_bib0031) 2016; 43
Ferrero (10.1016/j.ijrobp.2023.10.004_bib0030) 2015; 89
Matsuo (10.1016/j.ijrobp.2023.10.004_bib0009) 2012; 83
Le Roux (10.1016/j.ijrobp.2023.10.004_bib0015) 2015; 56
Flakus (10.1016/j.ijrobp.2023.10.004_bib0032) 2023; 182
Salama (10.1016/j.ijrobp.2023.10.004_bib0004) 2012; 118
Ball (10.1016/j.ijrobp.2023.10.004_bib0001) 2019; 20
Berg (10.1016/j.ijrobp.2023.10.004_bib0029) 2021; 11
Lucia (10.1016/j.ijrobp.2023.10.004_bib0006) 2023; 15
Su (10.1016/j.ijrobp.2023.10.004_bib0024) 2017; 12
Le Roux (10.1016/j.ijrobp.2023.10.004_bib0013) 2019; 46
Siva (10.1016/j.ijrobp.2023.10.004_bib0027) 2016; 15
Bucknell (10.1016/j.ijrobp.2023.10.004_bib0012) 2018; 129
Spring Kong (10.1016/j.ijrobp.2023.10.004_bib0008) 2021; 110
Pinot (10.1016/j.ijrobp.2023.10.004_bib0020) 2023; 15
Takeda (10.1016/j.ijrobp.2023.10.004_bib0007) 2012; 85
Le Roux (10.1016/j.ijrobp.2023.10.004_bib0017) 2019; 49
Timmerman (10.1016/j.ijrobp.2023.10.004_bib0005) 2010; 303
Nelson (10.1016/j.ijrobp.2023.10.004_bib0022) 2014; 41
Palma (10.1016/j.ijrobp.2023.10.004_bib0002) 2019; 393
Kadoya (10.1016/j.ijrobp.2023.10.004_bib0021) 2016; 96
Blanc-Béguin (10.1016/j.ijrobp.2023.10.004_bib0019) 2022; 15
Johnson (10.1016/j.ijrobp.2023.10.004_bib0025) 1997; 24
Bailey (10.1016/j.ijrobp.2023.10.004_bib0016) 2016; 46
Milano (10.1016/j.ijrobp.2023.10.004_bib0003) 2012; 83
Hofman (10.1016/j.ijrobp.2023.10.004_bib0014) 2011; 52
Noël (10.1016/j.ijrobp.2023.10.004_bib0018) 2022; 26
10.1016/j.ijrobp.2023.10.004_bib0023
References_xml – volume: 110
  start-page: 172
  year: 2021
  end-page: 187
  ident: bib0008
  article-title: Organs at risk considerations for thoracic stereotactic body radiation therapy: What is safe for lung parenchyma?
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Zhao
– volume: 303
  start-page: 1070
  year: 2010
  end-page: 1076
  ident: bib0005
  article-title: Stereotactic body radiation therapy for inoperable early stage lung cancer
  publication-title: JAMA
  contributor:
    fullname: Galvin
– volume: 46
  start-page: 1596
  year: 2019
  end-page: 1604
  ident: bib0013
  article-title: Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study
  publication-title: Eur J Nucl Med Mol Imaging
  contributor:
    fullname: Callahan
– volume: 129
  start-page: 196
  year: 2018
  end-page: 208
  ident: bib0012
  article-title: Functional lung imaging in radiation therapy for lung cancer: A systematic review and meta-analysis
  publication-title: Radiother Oncol
  contributor:
    fullname: Bressel
– volume: 11
  year: 2021
  ident: bib0029
  article-title: Lung function after stereotactic body radiation therapy for early-stage non-small cell lung cancer, changes and predictive markers
  publication-title: Front Oncol
  contributor:
    fullname: Haugstvedt
– volume: 85
  start-page: 636
  year: 2012
  end-page: 642
  ident: bib0007
  article-title: Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours
  publication-title: Br J Radiol
  contributor:
    fullname: Kunieda
– volume: 41
  start-page: 202
  year: 2014
  ident: bib0022
  article-title: SU-E-J-198: Evaluation of a free-form intensity-based deformable registration method using the POPI model
  publication-title: Med Phys
  contributor:
    fullname: Piper
– volume: 24
  start-page: 492
  year: 1997
  end-page: 499
  ident: bib0025
  article-title: Second lung cancers in patients successfully treated for lung cancer
  publication-title: Semin Oncol
  contributor:
    fullname: Chute
– volume: 43
  start-page: 33
  year: 2016
  ident: bib0031
  article-title: Estimating lung ventilation directly from 4D CT Hounsfield unit values
  publication-title: Med Phys
  contributor:
    fullname: Siva
– volume: 182
  year: 2023
  ident: bib0032
  article-title: Metrics of dose to highly ventilated lung are predictive of radiation-induced pneumonitis in lung cancer patients
  publication-title: Radiother Oncol
  contributor:
    fullname: Wallat
– volume: 46
  start-page: 428
  year: 2016
  end-page: 435
  ident: bib0016
  article-title: Ga PET ventilation and perfusion lung imaging-current status and future challenges
  publication-title: Semin Nucl Med
  contributor:
    fullname: Schembri
– volume: 33
  start-page: 157
  year: 2010
  end-page: 163
  ident: bib0026
  article-title: Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ
  publication-title: Am J Clin Oncol
  contributor:
    fullname: Okunieff
– volume: 12
  start-page: 219
  year: 2017
  end-page: 227
  ident: bib0024
  article-title: Risk of second primary malignancies in lung cancer survivors—The influence of different treatments
  publication-title: Target Oncol
  contributor:
    fullname: Chen
– volume: 15
  start-page: 114
  year: 2016
  end-page: 121
  ident: bib0027
  article-title: Ga-68 MAA perfusion 4D-PET/CT scanning allows for functional lung avoidance using conformal radiation therapy planning
  publication-title: Technol Cancer Res Treat
  contributor:
    fullname: Ball
– volume: 96
  start-page: 422
  year: 2016
  end-page: 431
  ident: bib0021
  article-title: Multi-institutional validation study of commercially available deformable image registration software for thoracic images
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Saito
– volume: 83
  start-page: 878
  year: 2012
  end-page: 886
  ident: bib0003
  article-title: Oligometastases treated with stereotactic body radiotherapy: Long-term follow-up of prospective study
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Zhang
– volume: 8
  year: 2021
  ident: bib0011
  article-title: Radiation therapy planning of thoracic tumors: A review of challenges associated with lung toxicities and potential perspectives of gallium-68 lung PET/CT imaging
  publication-title: Front Med (Lausanne)
  contributor:
    fullname: Blanc-Béguin
– volume: 102
  start-page: 1255
  year: 2018
  end-page: 1264
  ident: bib0028
  article-title: Correlation of functional lung heterogeneity and dosimetry to radiation pneumonitis using perfusion SPECT/CT and FDG PET/CT imaging
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Vesselle
– volume: 15
  start-page: 2166
  year: 2023
  ident: bib0020
  article-title: New automated method for lung functional volumes delineation with lung perfusion PET/CT imaging
  publication-title: Cancers (Basel)
  contributor:
    fullname: Bourbonne
– volume: 20
  start-page: 494
  year: 2019
  end-page: 503
  ident: bib0001
  article-title: Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): A phase 3, open-label, randomised controlled trial
  publication-title: Lancet Oncol
  contributor:
    fullname: Vinod
– volume: 49
  start-page: 71
  year: 2019
  end-page: 81
  ident: bib0017
  article-title: PET/CT lung ventilation and perfusion scanning using Galligas and gallium-68-MAA
  publication-title: Semin Nucl Med
  contributor:
    fullname: Siva
– volume: 56
  start-page: 1718
  year: 2015
  end-page: 1723
  ident: bib0015
  article-title: Correlation of
  publication-title: J Nucl Med
  contributor:
    fullname: Steinfort
– volume: 15
  start-page: 518
  year: 2022
  ident: bib0019
  article-title: Radiopharmaceutical labelling for lung ventilation/perfusion PET/CT imaging: A review of production and optimization processes for clinical use
  publication-title: Pharmaceuticals (Basel)
  contributor:
    fullname: Robin
– volume: 15
  start-page: 1726
  year: 2023
  ident: bib0006
  article-title: A feasibility study of functional lung volume preservation during stereotactic body radiotherapy guided by gallium-68 perfusion PET/CT
  publication-title: Cancers
  contributor:
    fullname: Pinot
– volume: 26
  start-page: 59
  year: 2022
  end-page: 75
  ident: bib0018
  article-title: Organs at risk radiation dose constraints
  publication-title: Cancer Radiother
  contributor:
    fullname: Antoni
– volume: 89
  start-page: 350
  year: 2015
  end-page: 356
  ident: bib0030
  article-title: Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: A prospective study
  publication-title: Lung Cancer
  contributor:
    fullname: Filippi
– volume: 118
  start-page: 2962
  year: 2012
  end-page: 2970
  ident: bib0004
  article-title: Stereotactic body radiotherapy for multisite extracranial oligometastases
  publication-title: Cancer
  contributor:
    fullname: Chmura
– volume: 52
  start-page: 1513
  year: 2011
  end-page: 1519
  ident: bib0014
  article-title: Ga PET/CT ventilation-perfusion imaging for pulmonary embolism: A pilot study with comparison to conventional scintigraphy
  publication-title: J Nucl Med
  contributor:
    fullname: Barber
– volume: 83
  start-page: e545
  year: 2012
  end-page: e549
  ident: bib0009
  article-title: Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Nakamura
– volume: 393
  start-page: 2051
  year: 2019
  end-page: 2058
  ident: bib0002
  article-title: Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial
  publication-title: Lancet
  contributor:
    fullname: Harrow
– volume: 7
  year: 2022
  ident: bib0010
  article-title: Symptomatic radiation pneumonitis after stereotactic body radiation therapy for multiple pulmonary oligometastases or synchronous primary lung cancer
  publication-title: Adv Radiat Oncol
  contributor:
    fullname: Yoneyama
– volume: 118
  start-page: 2962
  year: 2012
  ident: 10.1016/j.ijrobp.2023.10.004_bib0004
  article-title: Stereotactic body radiotherapy for multisite extracranial oligometastases
  publication-title: Cancer
  doi: 10.1002/cncr.26611
  contributor:
    fullname: Salama
– volume: 15
  start-page: 2166
  year: 2023
  ident: 10.1016/j.ijrobp.2023.10.004_bib0020
  article-title: New automated method for lung functional volumes delineation with lung perfusion PET/CT imaging
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers15072166
  contributor:
    fullname: Pinot
– volume: 43
  start-page: 33
  year: 2016
  ident: 10.1016/j.ijrobp.2023.10.004_bib0031
  article-title: Estimating lung ventilation directly from 4D CT Hounsfield unit values
  publication-title: Med Phys
  doi: 10.1118/1.4937599
  contributor:
    fullname: Kipritidis
– volume: 15
  start-page: 114
  year: 2016
  ident: 10.1016/j.ijrobp.2023.10.004_bib0027
  article-title: Ga-68 MAA perfusion 4D-PET/CT scanning allows for functional lung avoidance using conformal radiation therapy planning
  publication-title: Technol Cancer Res Treat
  doi: 10.1177/1533034614565534
  contributor:
    fullname: Siva
– volume: 33
  start-page: 157
  year: 2010
  ident: 10.1016/j.ijrobp.2023.10.004_bib0026
  article-title: Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ
  publication-title: Am J Clin Oncol
  doi: 10.1097/COC.0b013e3181979238
  contributor:
    fullname: Milano
– volume: 85
  start-page: 636
  year: 2012
  ident: 10.1016/j.ijrobp.2023.10.004_bib0007
  article-title: Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours
  publication-title: Br J Radiol
  doi: 10.1259/bjr/71635286
  contributor:
    fullname: Takeda
– volume: 24
  start-page: 492
  year: 1997
  ident: 10.1016/j.ijrobp.2023.10.004_bib0025
  article-title: Second lung cancers in patients successfully treated for lung cancer
  publication-title: Semin Oncol
  contributor:
    fullname: Johnson
– volume: 46
  start-page: 428
  year: 2016
  ident: 10.1016/j.ijrobp.2023.10.004_bib0016
  article-title: 68Ga PET ventilation and perfusion lung imaging-current status and future challenges
  publication-title: Semin Nucl Med
  doi: 10.1053/j.semnuclmed.2016.04.007
  contributor:
    fullname: Bailey
– volume: 12
  start-page: 219
  year: 2017
  ident: 10.1016/j.ijrobp.2023.10.004_bib0024
  article-title: Risk of second primary malignancies in lung cancer survivors—The influence of different treatments
  publication-title: Target Oncol
  doi: 10.1007/s11523-016-0459-0
  contributor:
    fullname: Su
– volume: 83
  start-page: 878
  year: 2012
  ident: 10.1016/j.ijrobp.2023.10.004_bib0003
  article-title: Oligometastases treated with stereotactic body radiotherapy: Long-term follow-up of prospective study
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2011.08.036
  contributor:
    fullname: Milano
– volume: 303
  start-page: 1070
  year: 2010
  ident: 10.1016/j.ijrobp.2023.10.004_bib0005
  article-title: Stereotactic body radiation therapy for inoperable early stage lung cancer
  publication-title: JAMA
  doi: 10.1001/jama.2010.261
  contributor:
    fullname: Timmerman
– volume: 11
  year: 2021
  ident: 10.1016/j.ijrobp.2023.10.004_bib0029
  article-title: Lung function after stereotactic body radiation therapy for early-stage non-small cell lung cancer, changes and predictive markers
  publication-title: Front Oncol
  doi: 10.3389/fonc.2021.674731
  contributor:
    fullname: Berg
– volume: 110
  start-page: 172
  year: 2021
  ident: 10.1016/j.ijrobp.2023.10.004_bib0008
  article-title: Organs at risk considerations for thoracic stereotactic body radiation therapy: What is safe for lung parenchyma?
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2018.11.028
  contributor:
    fullname: Spring Kong
– volume: 15
  start-page: 1726
  year: 2023
  ident: 10.1016/j.ijrobp.2023.10.004_bib0006
  article-title: A feasibility study of functional lung volume preservation during stereotactic body radiotherapy guided by gallium-68 perfusion PET/CT
  publication-title: Cancers
  doi: 10.3390/cancers15061726
  contributor:
    fullname: Lucia
– volume: 393
  start-page: 2051
  year: 2019
  ident: 10.1016/j.ijrobp.2023.10.004_bib0002
  article-title: Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)32487-5
  contributor:
    fullname: Palma
– volume: 96
  start-page: 422
  year: 2016
  ident: 10.1016/j.ijrobp.2023.10.004_bib0021
  article-title: Multi-institutional validation study of commercially available deformable image registration software for thoracic images
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2016.05.012
  contributor:
    fullname: Kadoya
– volume: 7
  year: 2022
  ident: 10.1016/j.ijrobp.2023.10.004_bib0010
  article-title: Symptomatic radiation pneumonitis after stereotactic body radiation therapy for multiple pulmonary oligometastases or synchronous primary lung cancer
  publication-title: Adv Radiat Oncol
  contributor:
    fullname: Kishi
– volume: 46
  start-page: 1596
  year: 2019
  ident: 10.1016/j.ijrobp.2023.10.004_bib0013
  article-title: Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-019-04338-z
  contributor:
    fullname: Le Roux
– volume: 89
  start-page: 350
  year: 2015
  ident: 10.1016/j.ijrobp.2023.10.004_bib0030
  article-title: Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: A prospective study
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2015.06.019
  contributor:
    fullname: Ferrero
– ident: 10.1016/j.ijrobp.2023.10.004_bib0023
– volume: 102
  start-page: 1255
  year: 2018
  ident: 10.1016/j.ijrobp.2023.10.004_bib0028
  article-title: Correlation of functional lung heterogeneity and dosimetry to radiation pneumonitis using perfusion SPECT/CT and FDG PET/CT imaging
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2018.05.051
  contributor:
    fullname: Lee
– volume: 83
  start-page: e545
  year: 2012
  ident: 10.1016/j.ijrobp.2023.10.004_bib0009
  article-title: Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2012.01.018
  contributor:
    fullname: Matsuo
– volume: 26
  start-page: 59
  year: 2022
  ident: 10.1016/j.ijrobp.2023.10.004_bib0018
  article-title: Organs at risk radiation dose constraints
  publication-title: Cancer Radiother
  doi: 10.1016/j.canrad.2021.11.001
  contributor:
    fullname: Noël
– volume: 56
  start-page: 1718
  year: 2015
  ident: 10.1016/j.ijrobp.2023.10.004_bib0015
  article-title: Correlation of 68Ga ventilation-perfusion PET/CT with pulmonary function test indices for assessing lung function
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.115.162586
  contributor:
    fullname: Le Roux
– volume: 8
  year: 2021
  ident: 10.1016/j.ijrobp.2023.10.004_bib0011
  article-title: Radiation therapy planning of thoracic tumors: A review of challenges associated with lung toxicities and potential perspectives of gallium-68 lung PET/CT imaging
  publication-title: Front Med (Lausanne)
  contributor:
    fullname: Lucia
– volume: 15
  start-page: 518
  year: 2022
  ident: 10.1016/j.ijrobp.2023.10.004_bib0019
  article-title: Radiopharmaceutical labelling for lung ventilation/perfusion PET/CT imaging: A review of production and optimization processes for clinical use
  publication-title: Pharmaceuticals (Basel)
  doi: 10.3390/ph15050518
  contributor:
    fullname: Blanc-Béguin
– volume: 52
  start-page: 1513
  year: 2011
  ident: 10.1016/j.ijrobp.2023.10.004_bib0014
  article-title: 68Ga PET/CT ventilation-perfusion imaging for pulmonary embolism: A pilot study with comparison to conventional scintigraphy
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.111.093344
  contributor:
    fullname: Hofman
– volume: 41
  start-page: 202
  year: 2014
  ident: 10.1016/j.ijrobp.2023.10.004_bib0022
  article-title: SU-E-J-198: Evaluation of a free-form intensity-based deformable registration method using the POPI model
  publication-title: Med Phys
  doi: 10.1118/1.4888251
  contributor:
    fullname: Nelson
– volume: 20
  start-page: 494
  year: 2019
  ident: 10.1016/j.ijrobp.2023.10.004_bib0001
  article-title: Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): A phase 3, open-label, randomised controlled trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(18)30896-9
  contributor:
    fullname: Ball
– volume: 182
  year: 2023
  ident: 10.1016/j.ijrobp.2023.10.004_bib0032
  article-title: Metrics of dose to highly ventilated lung are predictive of radiation-induced pneumonitis in lung cancer patients
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2023.109553
  contributor:
    fullname: Flakus
– volume: 129
  start-page: 196
  year: 2018
  ident: 10.1016/j.ijrobp.2023.10.004_bib0012
  article-title: Functional lung imaging in radiation therapy for lung cancer: A systematic review and meta-analysis
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2018.07.014
  contributor:
    fullname: Bucknell
– volume: 49
  start-page: 71
  year: 2019
  ident: 10.1016/j.ijrobp.2023.10.004_bib0017
  article-title: PET/CT lung ventilation and perfusion scanning using Galligas and gallium-68-MAA
  publication-title: Semin Nucl Med
  doi: 10.1053/j.semnuclmed.2018.10.013
  contributor:
    fullname: Le Roux
SSID ssj0001174
Score 2.5005367
Snippet The aim of this work was to compare anatomic and functional dose-volume parameters as predictors of acute radiation-induced lung toxicity (RILT) in patients...
PURPOSEThe aim of this work was to compare anatomic and functional dose-volume parameters as predictors of acute radiation-induced lung toxicity (RILT) in...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 952
Title Prediction of Acute Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy Using Dose-Volume Parameters From Functional Mapping on Gallium 68 Perfusion Positron Emission Tomography/Computed Tomography
URI https://dx.doi.org/10.1016/j.ijrobp.2023.10.004
https://www.ncbi.nlm.nih.gov/pubmed/37875246
https://search.proquest.com/docview/2881710657
Volume 118
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELb2IQEXxJvykpG4RSlN4qTpsUCrFdsuaOlCb1FiOyLVtl51G4nyV_kzzNhJnFVZsXCJqpFsRZ0vM5_H8yDkjfRkHucec3MJRxQmM-Gmg0C4QuhRt2HQy7B2eHoSHZ2xj_Nwvrd_u5W1VG6yLv_5x7qS_9EqyECvWCX7D5ptNgUB_Ab9whM0DM8b6fjzGq9Zas435Hjnf4rNBlDk4lQOvN2fwPfszNSPgiPjHuqh4F_gIdVGV0g575TY2nWYhIGNBhyTTfBBXUr3q7ZhQDcxlQv7cQLhVUtnDE6xiiVO0wtdeYVNOtLz86JcOlGM-fV5ifE4HApcYNTdGQGwtGSmllW7bOzRa4ZLiJa0TZuvxi1b3S7WzVurFW8KbzJbg2MiN83BYVJykx2MhF0nCfRVYW8KYONqPnMr1x_8RrFS2llhs-OtNdrLrd5rqr7D3yLaARSfYQaZKSHtSmP04_7ABd41v-IVrFuwMQ9t4wem5W5FFwbGmex4IhMUWXSLxVpl2BjVD7o6jZBZz1tnG5x8SsZnk0kyG81n--TQB5sJxvpweHz67bihFR6cHevaT52guLvzddzqurOT5lCze-RudfihQ4Pk-2RPrh6QW9MqveMh-WUBTVVONaDpDqApAprWgKYa0LQNaIqAtutoBWiqAU1bgKYW0BQBTS2gaQVoCusrQNMopg2gaQ1oWgOaWui-reHckj0iZ-PR7P2RW00fcXkQ9jdulAeelws_FFxHJXgEbLuXp54EryXSVHhRmgcZ76WM9VIuox5nPIqFEIEv8zQLHpODlVrJp4TykPkiiPt-JgSTkqVZFjGZ80BEYMi9uEPcWm_JhWkyk9TZl4vE6DlBPaMU9Nwh_Vq5SUWUDQFOAH1_Wfm6xkIC_w5eDqYrqcrLxI9jD04bUdjvkCcGJM27BODVQ59Fz26w-jm5Yz-yF-Rgsy7lS-Dtm-xVhejfdM8Ajg
link.rule.ids 315,783,787,27936,27937
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prediction+of+Acute+Radiation-Induced+Lung+Toxicity+After+Stereotactic+Body+Radiation+Therapy+Using+Dose-Volume+Parameters+From+Functional+Mapping+on+Gallium+68+Perfusion+Positron+Emission+Tomography%2FComputed+Tomography&rft.jtitle=International+journal+of+radiation+oncology%2C+biology%2C+physics&rft.au=Lucia%2C+Fran%C3%A7ois&rft.au=Bourhis%2C+David&rft.au=Pinot%2C+Fanny&rft.au=Hamya%2C+Mohamed&rft.date=2024-03-15&rft.eissn=1879-355X&rft.volume=118&rft.issue=4&rft.spage=952&rft.epage=962&rft_id=info:doi/10.1016%2Fj.ijrobp.2023.10.004&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0360-3016&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0360-3016&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0360-3016&client=summon